scholarly journals Transfer Learning in Biomedical Named Entity Recognition: An Evaluation of BERT in the PharmaCoNER task

2019 ◽  
Author(s):  
Cong Sun ◽  
Zhihao Yang
Keyword(s):  
Transfer Learning ◽  
Named Entity Recognition ◽  
Entity Recognition ◽  
Named Entity ◽  
Biomedical Named Entity Recognition

scholarly journals Combining Multi-task Learning with Transfer Learning for Biomedical Named Entity Recognition

2020 ◽  
Vol 176 ◽  
pp. 848-857 ◽  
Author(s):  
Tahir Mehmood ◽  
Alfonso E. Gerevini ◽  
Alberto Lavelli ◽  
Ivan Serina
Keyword(s):  
Transfer Learning ◽  
Named Entity Recognition ◽  
Entity Recognition ◽  
Named Entity ◽  
Task Learning ◽  
Biomedical Named Entity Recognition

scholarly journals We are not ready yet: limitations of transfer learning for Disease Named Entity Recognition

2021 ◽  
Author(s):  
Lisa Langnickel ◽  
Juliane Fluck
Keyword(s):  
Transfer Learning ◽  
Language Processing ◽  
State Of The Art ◽  
Named Entity Recognition ◽  
Clinical Applications ◽  
Entity Recognition ◽  
Data Sets ◽  
Named Entity ◽  
Current State ◽  
Biomedical Named Entity Recognition

Intense research has been done in the area of biomedical natural language processing. Since the breakthrough of transfer learning-based methods, BERT models are used in a variety of biomedical and clinical applications. For the available data sets, these models show excellent results - partly exceeding the inter-annotator agreements. However, biomedical named entity recognition applied on COVID-19 preprints shows a performance drop compared to the results on available test data. The question arises how well trained models are able to predict on completely new data, i.e. to generalize. Based on the example of disease named entity recognition, we investigate the robustness of different machine learning-based methods - thereof transfer learning - and show that current state-of-the-art methods work well for a given training and the corresponding test set but experience a significant lack of generalization when applying to new data. We therefore argue that there is a need for larger annotated data sets for training and testing.

scholarly journals Hierarchical shared transfer learning for biomedical named entity recognition

2022 ◽  
Vol 23 (1) ◽  
Author(s):  
Zhaoying Chai ◽  
Han Jin ◽  
Shenghui Shi ◽  
Siyan Zhan ◽  
Lin Zhuo ◽  
...  
Keyword(s):  
Deep Learning ◽  
Transfer Learning ◽  
Medical Information ◽  
Named Entity Recognition ◽  
Fine Tuning ◽  
Entity Recognition ◽  
Single Task ◽  
Named Entity ◽  
Task Learning ◽  
Biomedical Named Entity Recognition

Abstract Background Biomedical named entity recognition (BioNER) is a basic and important medical information extraction task to extract medical entities with special meaning from medical texts. In recent years, deep learning has become the main research direction of BioNER due to its excellent data-driven context coding ability. However, in BioNER task, deep learning has the problem of poor generalization and instability. Results we propose the hierarchical shared transfer learning, which combines multi-task learning and fine-tuning, and realizes the multi-level information fusion between the underlying entity features and the upper data features. We select 14 datasets containing 4 types of entities for training and evaluate the model. The experimental results showed that the F1-scores of the five gold standard datasets BC5CDR-chemical, BC5CDR-disease, BC2GM, BC4CHEMD, NCBI-disease and LINNAEUS were increased by 0.57, 0.90, 0.42, 0.77, 0.98 and − 2.16 compared to the single-task XLNet-CRF model. BC5CDR-chemical, BC5CDR-disease and BC4CHEMD achieved state-of-the-art results.The reasons why LINNAEUS’s multi-task results are lower than single-task results are discussed at the dataset level. Conclusion Compared with using multi-task learning and fine-tuning alone, the model has more accurate recognition ability of medical entities, and has higher generalization and stability.

CRFs based parallel biomedical named entity recognition algorithm employing MapReduce framework

2015 ◽  
Vol 18 (2) ◽  
pp. 493-505 ◽  
Author(s):  
Zhuo Tang ◽  
Lingang Jiang ◽  
Li Yang ◽  
Kenli Li ◽  
Keqin Li
Keyword(s):  
Named Entity Recognition ◽  
Recognition Algorithm ◽  
Entity Recognition ◽  
Mapreduce Framework ◽  
Named Entity ◽  
Biomedical Named Entity Recognition

scholarly journals NERO: a biomedical named-entity (recognition) ontology with a large, annotated corpus reveals meaningful associations through text embedding

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Kanix Wang ◽  
Robert Stevens ◽  
Halima Alachram ◽  
Yu Li ◽  
Larisa Soldatova ◽  
...  
Keyword(s):  
Named Entity Recognition ◽  
Entity Recognition ◽  
Analysis Tool ◽  
Automated Extraction ◽  
Named Entities ◽  
Named Entity ◽  
Automated Knowledge ◽  
Biomedical Texts ◽  
Machine Reading ◽  
Biomedical Named Entity Recognition

AbstractMachine reading (MR) is essential for unlocking valuable knowledge contained in millions of existing biomedical documents. Over the last two decades1,2, the most dramatic advances in MR have followed in the wake of critical corpus development3. Large, well-annotated corpora have been associated with punctuated advances in MR methodology and automated knowledge extraction systems in the same way that ImageNet4 was fundamental for developing machine vision techniques. This study contributes six components to an advanced, named entity analysis tool for biomedicine: (a) a new, Named Entity Recognition Ontology (NERO) developed specifically for describing textual entities in biomedical texts, which accounts for diverse levels of ambiguity, bridging the scientific sublanguages of molecular biology, genetics, biochemistry, and medicine; (b) detailed guidelines for human experts annotating hundreds of named entity classes; (c) pictographs for all named entities, to simplify the burden of annotation for curators; (d) an original, annotated corpus comprising 35,865 sentences, which encapsulate 190,679 named entities and 43,438 events connecting two or more entities; (e) validated, off-the-shelf, named entity recognition (NER) automated extraction, and; (f) embedding models that demonstrate the promise of biomedical associations embedded within this corpus.

scholarly journals BioALBERT: A Simple and Effective Pre-trained Language Model for Biomedical Named Entity Recognition

2020 ◽  
Author(s):  
Usman Naseem ◽  
Matloob Khushi ◽  
Vinay Reddy ◽  
Sakthivel Rajendran ◽  
Imran Razzak ◽  
...  
Keyword(s):  
State Of The Art ◽  
Language Model ◽  
Named Entity Recognition ◽  
Training Data ◽  
Entity Recognition ◽  
Future Research ◽  
Named Entity ◽  
Domain Specific ◽  
Context Dependent ◽  
Biomedical Named Entity Recognition

Abstract Background: In recent years, with the growing amount of biomedical documents, coupled with advancement in natural language processing algorithms, the research on biomedical named entity recognition (BioNER) has increased exponentially. However, BioNER research is challenging as NER in the biomedical domain are: (i) often restricted due to limited amount of training data, (ii) an entity can refer to multiple types and concepts depending on its context and, (iii) heavy reliance on acronyms that are sub-domain specific. Existing BioNER approaches often neglect these issues and directly adopt the state-of-the-art (SOTA) models trained in general corpora which often yields unsatisfactory results. Results: We propose biomedical ALBERT (A Lite Bidirectional Encoder Representations from Transformers for Biomedical Text Mining) - bioALBERT - an effective domain-specific pre-trained language model trained on huge biomedical corpus designed to capture biomedical context-dependent NER. We adopted self-supervised loss function used in ALBERT that targets on modelling inter-sentence coherence to better learn context-dependent representations and incorporated parameter reduction strategies to minimise memory usage and enhance the training time in BioNER. In our experiments, BioALBERT outperformed comparative SOTA BioNER models on eight biomedical NER benchmark datasets with four different entity types. The performance is increased for; (i) disease type corpora by 7.47% (NCBI-disease) and 10.63% (BC5CDR-disease); (ii) drug-chem type corpora by 4.61% (BC5CDR-Chem) and 3.89 (BC4CHEMD); (iii) gene-protein type corpora by 12.25% (BC2GM) and 6.42% (JNLPBA); and (iv) Species type corpora by 6.19% (LINNAEUS) and 23.71% (Species-800) is observed which leads to a state-of-the-art results. Conclusions: The performance of proposed model on four different biomedical entity types shows that our model is robust and generalizable in recognizing biomedical entities in text. We trained four different variants of BioALBERT models which are available for the research community to be used in future research.

Sign in / Sign up

Export Citation Format

Share Document